FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Bert van der Reijden

Research Profile

Chemicals & Drugs

Disorders

Anatomy

Procedures

Physiology

Living Beings

Mouse

Concepts & Ideas

Molecular Sequence Data

Co-author Network

Publications

TOP 3
Willemijn Hobo; Joop H Jansen; Michel Kester; Frank W M B Preijers; NP Schaap; Ton Schattenberg; Bert A van der Reijden; Walter J F M van der Velden; Yannick Wouters; Niken Adisty; N M A Blijlevens; Kelly Broen; Theo de Witte; J H Frederik Falkenburg; Ton Feuth; Hanny Fredrix; Annelies Greupink-Draaisma; Harry Dolstra
Association of disparities in known minor histocompatibility antigens with relapse-free survival and graft-versus-host disease after allogeneic stem cell transplantation.
Cyrus Khandanpour; Joseph Krongold; Bob Löwenberg; Sara E Meyer; Chandrashekhar V Patel; Justine K Peeters; Judith Schütte; Bert A van der Reijden; Lothar Vassen; Frederique Bouwman; Fernando J Calero-Nieto; Riyan Chen; Evangelia Diamanti; Ulrich Dührsen; Marie-Claude Gaudreau; Bertie Göttgens; H Leighton Grimes; Rebecca Hannah; Joop H Jansen; Tarik Möröy
The human GFI136N variant induces epigenetic changes at the Hoxa9 locus and accelerates K-RAS driven myeloproliferative disorder in mice.
Judith J Smit; Bert A van der Reijden; Willem J van Dijk; Davide Monteferrario; Sylvie M Noordermeer; Titia K Sixma
The E3 ligase HOIP specifies linear ubiquitin chain assembly through its RING-IBR-RING domain and the unique LDD extension.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Bert van der Reijden (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Willemijn Hobo; Joop H Jansen; Michel Kester; Frank W M B Preijers; NP Schaap; Ton Schattenberg; Bert A van der Reijden; Walter J F M van der Velden; Yannick Wouters; Niken Adisty; N M A Blijlevens; Kelly Broen; Theo de Witte; J H Frederik Falkenburg; Ton Feuth; Hanny Fredrix; Annelies Greupink-Draaisma; Harry Dolstra
Association of disparities in known minor histocompatibility antigens with relapse-free survival and graft-versus-host disease after allogeneic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2013;19(2):274-82.
2012: Cyrus Khandanpour; Joseph Krongold; Bob Löwenberg; Sara E Meyer; Chandrashekhar V Patel; Justine K Peeters; Judith Schütte; Bert A van der Reijden; Lothar Vassen; Frederique Bouwman; Fernando J Calero-Nieto; Riyan Chen; Evangelia Diamanti; Ulrich Dührsen; Marie-Claude Gaudreau; Bertie Göttgens; H Leighton Grimes; Rebecca Hannah; Joop H Jansen; Tarik Möröy
The human GFI136N variant induces epigenetic changes at the Hoxa9 locus and accelerates K-RAS driven myeloproliferative disorder in mice.
Blood 2012;120(19):4006-17.
2012: Judith J Smit; Bert A van der Reijden; Willem J van Dijk; Davide Monteferrario; Sylvie M Noordermeer; Titia K Sixma
The E3 ligase HOIP specifies linear ubiquitin chain assembly through its RING-IBR-RING domain and the unique LDD extension.
The EMBO journal 2012;31(19):3833-44.
2012: Maaike Luesink; Dirk Reinhardt; Jan Trka; Marry M van den Heuvel-Eibrink; Bert A van der Reijden; Vincent H J van der Velden; C Michel Zwaan; Andre Baruchel; Jan B M Boezeman; Valérie de Haas; Iris H I M Hollink; Ruth H J N Knops; Joop H Jansen
High GATA2 expression is a poor prognostic marker in pediatric acute myeloid leukemia.
Blood 2012;120(10):2064-75.
2012: Sylvie M Noordermeer; Paul N Span; Fred C G J Sweep; Evelyn Tönnissen; Adrian van der Heijden; Saskia M Bergevoet; Joop H Jansen; Marloes Wennemers; Bert A van der Reijden
Expression of the BRCA1 complex member BRE predicts disease free survival in breast cancer.
Breast cancer research and treatment 2012;135(1):125-33.
2012: Gerco Hassink; Judith Klumperman; Davide Monteferrario; Sylvie M Noordermeer; Viola Oorschot; Johan Slotman; Bert A van der Reijden; Peter van Kerkhof; Ger J Strous
Identification of the ubiquitin ligase Triad1 as a regulator of endosomal transport.
Biology open 2012;1(6):607-14.
2012: Sylvie M Noordermeer; Mathijs A Sanders; Lars Bullinger; Joop H Jansen; Davide Monteferrario; Bert A van der Reijden
Improved classification of MLL-AF9-positive acute myeloid leukemia patients based on BRE and EVI1 expression.
Blood 2012;119(18):4335-7.
2012: Leilei Tang; Greet Bakker-Verweij; Saskia M Bergevoet; Theo de Witte; Piero C Giordano; Cornelis L Harteveld; Joop H Jansen; Leo Nijtmans; Reinier A P Raymakers; Bert A van der Reijden
Human mitochondrial ATP-binding cassette transporter ABCB10 is required for efficient red blood cell development.
British journal of haematology 2012;157(1):151-4.
2012: Leonie I Kroeze; Roland P Kuiper; Gorica Nikoloski; Heike L Pahl; Susanne Schnittger; Ellen Stevens-Linders; Bert A van der Reijden; Patricia van Hoogen; Pedro da Silva-Coelho; Torsten Haferlach; Joop H Jansen
Genetic defects in PRC2 components other than EZH2 are not common in myeloid malignancies.
Blood 2012;119(5):1318-9.
2012: Gorica Nikoloski; Bert A van der Reijden; Joop H Jansen
Mutations in epigenetic regulators in myelodysplastic syndromes.
International journal of hematology 2012;95(1):8-16.
2011: Sylvie M Noordermeer; Mathijs A Sanders; Evelyn Tönnissen; Peter J M Valk; Adrian van der Heijden; Lars Bullinger; Konstanze Döhner; Christian Gilissen; Joop H Jansen; Bert A van der Reijden
High BRE expression predicts favorable outcome in adult acute myeloid leukemia, in particular among MLL-AF9-positive patients.
Blood 2011;118(20):5613-21.
2011: L D de Hosson; H P H Kremer; Dirk J Lefeber; Dietger Niederwieser; Frank W M B Preijers; NP Schaap; H Al-Ali; Wil Allebes; N M A Blijlevens; B P C van de Warrenburg; Bert A van der Reijden; A V M B Schattenberg
Adult metachromatic leukodystrophy treated by allo-SCT and a review of the literature.
Bone marrow transplantation 2011;46(8):1071-6.
2011: Sylvie M Noordermeer; Evelyn Tönnissen; Inge Vissers; Adrian van der Heijden; Louis T van de Locht; Piëtte P Deutz-Terlouw; Erik W A Marijt; Joop H Jansen; Bert A van der Reijden
Rapid identification of IDH1 and IDH2 mutations in acute myeloid leukaemia using high resolution melting curve analysis.
British journal of haematology 2011;152(4):493-6.
2010: L T van der Meer; Joop H Jansen; Bert A van der Reijden
Gfi1 and Gfi1b: key regulators of hematopoiesis.
Leukemia 2010;24(11):1834-43.
2010: Gorica Nikoloski; Saskia M C Langemeijer; Roland P Kuiper; Ruth Knops; Marion Massop; Evelyn R L T M Tönnissen; Adrian van der Heijden; Theresia N Scheele; Peter Vandenberghe; Theo de Witte; Bert A van der Reijden; Joop H Jansen
Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes.
Nature genetics 2010;42(8):665-7.
2010: Aneta M Schaap-Oziemlak; Reinier A P Raymakers; Saskia M Bergevoet; Christian Gilissen; Bastiaan Jan Herman Jansen; Gosse J Adema; Gesine Kögler; Carlos le Sage; Reuven Agami; Bert A van der Reijden; Joop H Jansen
MicroRNA hsa-miR-135b regulates mineralization in osteogenic differentiation of human unrestricted somatic stem cells.
Stem cells and development 2010;19(6):877-85.
2010: Marinus H J van Oers; Evelyn Tönnissen; Martine Van Glabbeke; Livia Giurgea; Joop H Jansen; Richard J Klasa; Robert E Marcus; Max Wolf; Eva Kimby; Andrej Vranovsky; Harald Holte; Anton Hagenbeek; Bert A van der Reijden
BCL-2/IgH polymerase chain reaction status at the end of induction treatment is not predictive for progression-free survival in relapsed/resistant follicular lymphoma: results of a prospective randomized EORTC 20981 phase III intergroup study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(13):2246-52.
2010: Cyrus Khandanpour; Christian Thiede; Peter J M Valk; Ehssan Sharif-Askari; Holger Nückel; Dietmar Lohmann; Bernhard Horsthemke; Winfried Siffert; Andreas Neubauer; Karl-Heinz Grzeschik; Clara D Bloomfield; Guido Marcucci; Kati Maharry; Marilyn L Slovak; Bert A van der Reijden; Joop H Jansen; Hans K Schackert; Khashayar Afshar; Susanne Schnittger; Justine K Peeters; Frank Kroschinsky; Gerhard Ehninger; Bob Lowenberg; Ulrich Dührsen; Tarik Möröy
A variant allele of Growth Factor Independence 1 (GFI1) is associated with acute myeloid leukemia.
Blood 2010;115(12):2462-72.
2010: Leilei Tang; Saskia M Bergevoet; Christian Gilissen; Theo de Witte; Joop H Jansen; Bert A van der Reijden; Reinier A P Raymakers
Hematopoietic stem cells exhibit a specific ABC transporter gene expression profile clearly distinct from other stem cells.
BMC pharmacology 2010;10():12.
2009: Maaike Luesink; Jeroen L A Pennings; Willemijn M Wissink; Peter C M Linssen; Petra Muus; Rolph Pfundt; Theo J M de Witte; Bert A van der Reijden; Joop H Jansen
Chemokine induction by all-trans retinoic acid and arsenic trioxide in acute promyelocytic leukemia: triggering the differentiation syndrome.
Blood 2009;114(27):5512-21.
2009: Daniela Cilloni; Aline Renneville; fabienne hermitte; Robert K Hills; Sarah Daly; Jelena V Jovanovic; Enrico Gottardi; Milena Fava; Susanne Schnittger; Tamara Weiss; Barbara Izzo; Josep Nomdedeu; Adrian van der Heijden; Bert A van der Reijden; Joop H Jansen; Vincent H J van der Velden; Hans Ommen; Claude Preudhomme; Giuseppe Saglio; David Grimwade
Real-time quantitative polymerase chain reaction detection of minimal residual disease by standardized WT1 assay to enhance risk stratification in acute myeloid leukemia: a European LeukemiaNet study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(31):5195-201.
2009: Jurgen A F Marteijn; L T van der Meer; J J Smit; S M Noordermeer; W Wissink; P Jansen; H G Swarts; R G Hibbert; Theo de Witte; T K Sixma; Joop H Jansen; Bert A van der Reijden
The ubiquitin ligase Triad1 inhibits myelopoiesis through UbcH7 and Ubc13 interacting domains.
Leukemia 2009;23(8):1480-9.
2009: W J F M van der Velden; N M A Blijlevens; Frans Maas; NP Schaap; Joop H Jansen; Bert A van der Reijden; Ton Feuth; Harry Dolstra; J Peter Donnelly
NOD2 polymorphisms predict severe acute graft-versus-host and treatment-related mortality in T-cell-depleted haematopoietic stem cell transplantation.
Bone marrow transplantation 2009;44(4):243-8.
2009: Saskia M C Langemeijer; Roland P Kuiper; Marieke Berends; Ruth Knops; Mariam G Aslanyan; Marion Massop; Ellen Stevens-Linders; Patricia van Hoogen; Ad Geurts van Kessel; Reinier A P Raymakers; Eveline J Kamping; Gregor E Verhoef; Estelle Verburgh; Anne Hagemeijer; Peter Vandenberghe; Theo de Witte; Bert A van der Reijden; Joop H Jansen
Acquired mutations in TET2 are common in myelodysplastic syndromes.
Nature genetics 2009;41(7):838-42.
2009: Lothar Vassen; Cyrus Khandanpour; Peter Ebeling; Bert A van der Reijden; Joop H Jansen; Stefan Mahlmann; Ulrich Dührsen; Tarik Möröy
Growth factor independent 1b (Gfi1b) and a new splice variant of Gfi1b are highly expressed in patients with acute and chronic leukemia.
International journal of hematology 2009;89(4):422-30.
2009: L Tang; S M Bergevoet; L E Franssen; Theo de Witte; Joop H Jansen; Reinier A P Raymakers; Bert A van der Reijden
Exclusion of ABCB8 and ABCB10 as cancer candidate genes in acute myeloid leukemia.
Leukemia 2009;23(5):1000-2.
2008: sake wageningen; Gorica Nikoloski; Gerty Vierwinden; Ruth Knops; Bert A van der Reijden; Joop H Jansen
The transcription factor nuclear factor Y regulates the proliferation of myeloid progenitor cells.
Haematologica 2008;93(10):1580-2.
2008: sake wageningen; Marleen C Breems-de Ridder; Jeannet Nigten; Gorica Nikoloski; Claudia A J Erpelinck-Verschueren; Bob Löwenberg; Theo de Witte; Daniel G Tenen; Bert A van der Reijden; Joop H Jansen
Gene transactivation without direct DNA binding defines a novel gain-of-function for PML-RARalpha.
Blood 2008;111(3):1634-43.
2007: Jurgen A F Marteijn; Laurens T van der Meer; Liesbeth van Emst; Simon van Reijmersdal; Willemijn Wissink; Theo de Witte; Joop H Jansen; Bert A van der Reijden
Gfi1 ubiquitination and proteasomal degradation is inhibited by the ubiquitin ligase Triad1.
Blood 2007;110(9):3128-35.
2007: J F M Jacobs; P P Brons; A Simons; Bert A van der Reijden; Peter M Hoogerbrugge
Therapy-related, donor-derived AML responding to a second allogeneic BMT.
Bone marrow transplantation 2007;40(5):499-500.
2007: Jurgen A F Marteijn; Laurens T van der Meer; Liesbeth van Emst; Theo de Witte; Joop H Jansen; Bert A van der Reijden
Diminished proteasomal degradation results in accumulation of Gfi1 protein in monocytes.
Blood 2007;109(1):100-8.
2006: Jurgen A F Marteijn; Joop H Jansen; Bert A van der Reijden
Ubiquitylation in normal and malignant hematopoiesis: novel therapeutic targets.
Leukemia 2006;20(9):1511-8.
2006: Marc H G P Raaijmakers; Elke P L M de Grouw; Bert A van der Reijden; Theo de Witte; Joop H Jansen; Reinier A P Raymakers
ABCB1 modulation does not circumvent drug extrusion from primitive leukemic progenitor cells and may preferentially target residual normal cells in acute myelogenous leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(11 Pt 1):3452-8.
2006: sake wageningen; Arie H Pennings; Bert A van der Reijden; Jan B M Boezeman; Frank de Lange; Joop H Jansen
Isolation of FRET-positive cells using single 408-nm laser flow cytometry.
Cytometry. Part A : the journal of the International Society for Analytical Cytology 2006;69(4):291-8.
2006: Elke P L M de Grouw; Marc H G P Raaijmakers; Jan B M Boezeman; Bert A van der Reijden; Louis van de Locht; Theo de Witte; Joop H Jansen; Reinier A P Raymakers
Preferential expression of a high number of ATP binding cassette transporters in both normal and leukemic CD34+CD38- cells.
Leukemia 2006;20(4):750-4.
2006: Bert A van der Reijden; Joop H Jansen
Diagnosis and monitoring of CBFB-MYH11-positive acute myeloid leukemia by qualitative and quantitative RT-PCR.
Methods in molecular medicine 2006;125():163-75.
2006: Joop H Jansen; Bert A van der Reijden
Isolation of RNA and DNA from leukocytes and cDNA synthesis.
Methods in molecular medicine 2006;125():1-11.
2005: Jurgen A F Marteijn; Liesbeth van Emst; Claudia A J Erpelinck-Verschueren; Gorica Nikoloski; Aswin L Menke; Theo de Witte; Bob Löwenberg; Joop H Jansen; Bert A van der Reijden
The E3 ubiquitin-protein ligase Triad1 inhibits clonogenic growth of primary myeloid progenitor cells.
Blood 2005;106(13):4114-23.
2005: Marc H G P Raaijmakers; Elke P L M de Grouw; Leonie H H Heuver; Bert A van der Reijden; Joop H Jansen; George Scheffer; Rik J Scheper; Theo de Witte; Reinier A P Raymakers
Impaired breast cancer resistance protein mediated drug transport in plasma cells in multiple myeloma.
Leukemia research 2005;29(12):1455-8.
2005: Aniek O de Graaf; J H J M van Krieken; Evelyn Tönnissen; Willemijn Wissink; Louis van de Locht; Ingrid Overes; Harry Dolstra; Theo de Witte; Bert A van der Reijden; Joop H Jansen
Expression of C-IAP1, C-IAP2 and SURVIVIN discriminates different types of lymphoid malignancies.
British journal of haematology 2005;130(6):852-9.
2005: Genyan Yang; Waleed Khalaf; Louis van de Locht; Joop H Jansen; Meihua Gao; Mary Ann Thompson; Bert A van der Reijden; David H Gutmann; Ruud Delwel; D Wade Clapp; Scott W Hiebert
Transcriptional repression of the Neurofibromatosis-1 tumor suppressor by the t(8;21) fusion protein.
Molecular and cellular biology 2005;25(14):5869-79.
2005: J Nigten; M C Breems-de Ridder; Claudia A J Erpelinck-Verschueren; G Nikoloski; Bert A van der Reijden; sake wageningen; P B van Hennik; Theo de Witte; Bob Löwenberg; Joop H Jansen
ID1 and ID2 are retinoic acid responsive genes and induce a G0/G1 accumulation in acute promyelocytic leukemia cells.
Leukemia 2005;19(5):799-805.
2005: Marc H G P Raaijmakers; Elke P L M de Grouw; Leonie H H Heuver; Bert A van der Reijden; Joop H Jansen; Rik J Scheper; George L Scheffer; Theo de Witte; Reinier A P Raymakers
Breast cancer resistance protein in drug resistance of primitive CD34+38- cells in acute myeloid leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(6):2436-44.
2004: Aniek O de Graaf; Lambert P van den Heuvel; Henry B P M Dijkman; Ronney A De Abreu; Kim U Birkenkamp; Theo de Witte; Bert A van der Reijden; Jan A M Smeitink; Joop H Jansen
Bcl-2 prevents loss of mitochondria in CCCP-induced apoptosis.
Experimental cell research 2004;299(2):533-40.
2004: Genyan Yang; Waleed Khalaf; Louis van de Locht; Joop H Jansen; Bert A van der Reijden; Carsten Müller-Tidow; H Ruud Delwel; Hubert Serve; D Wade Clapp; Scott W Hiebert
Epigenetic regulation of tumor suppressors in t(8:21)-containing AML.
Annals of hematology 2004;83(6):329-30.
2004: Genyan Yang; Waleed Khalaf; Louis van de Locht; Joop H Jansen; Bert A van der Reijden; Carsten Müller-Tidow; H Ruud Delwel; Hubert Serve; D Wade Clapp; Scott W Hiebert
Epigenetic regulation of tumor suppressors in t(8:21)-containing AML.
Annals of hematology 2004;83 Suppl 1():S83.
2003: Bert A van der Reijden; Marion Massop; Evelyn Tönnissen; Louis van de Locht; Petra Muus; Theo de Witte; Joop H Jansen
Rapid identification of CBFB-MYH11-positive acute myeloid leukemia (AML) cases by one single MYH11 real-time RT-PCR.
Blood 2003;101(12):5085-6.
2002: Johannes P Van Dijk; Leonie H H Heuver; Bert A van der Reijden; Reinier A P Raymakers; Theo de Witte; Joop H Jansen
A novel, essential control for clonality analysis with human androgen receptor gene polymerase chain reaction.
The American journal of pathology 2002;161(3):807-12.
2002: Bert A van der Reijden; Annet Simons; Erna Luiten; Sonja C van der Poel; Pauline E Hogenbirk; Evelyn Tönnissen; Peter J M Valk; Bob Löwenberg; Georgine E De Greef; Martijn H Breuning; Joop H Jansen
Minimal residual disease quantification in patients with acute myeloid leukaemia and inv(16)/CBFB-MYH11 gene fusion.
British journal of haematology 2002;118(2):411-8.
2002: Bryan Linggi; Carsten Müller-Tidow; Louis van de Locht; Ming Hu; John Nip; Hubert Serve; Wolfgang E Berdel; Bert A van der Reijden; Dawn E Quelle; Janet D Rowley; John Cleveland; Joop H Jansen; Pier Paolo Pandolfi; Scott W Hiebert
The t(8;21) fusion protein, AML1 ETO, specifically represses the transcription of the p14(ARF) tumor suppressor in acute myeloid leukemia.
Nature medicine 2002;8(7):743-50.
2001: J L Pennings; Louis van de Locht; Joop H Jansen; Bert A van der Reijden; Theo de Witte; E J B M Mensink
Degradable dU-based DNA template as a standard in real-time PCR quantitation.
Leukemia 2001;15(12):1962-5.
2001: Bert A van der Reijden; L de Wit; Sonja C van der Poel; E B Luiten; Marina Lafage-Pochitaloff; Nicole Dastugue; Jean Gabert; Bob Löwenberg; Joop H Jansen
Identification of a novel CBFB-MYH11 transcript: implications for RT-PCR diagnosis.
The hematology journal : the official journal of the European Haematology Association / EHA 2001;2(3):206-9.
2000: M P de Vetten; Joop H Jansen; Bert A van der Reijden; M S Berger; J M Zijlmans; Bob Löwenberg
Molecular remission of Philadelphia/bcr-abl-positive acute myeloid leukaemia after treatment with anti-CD33 calicheamicin conjugate (gemtuzumab ozogamicin, CMA-676).
British journal of haematology 2000;111(1):277-9.
1999: Hans Dauwerse; Elisabeth M E Smit; Rachel H Giles; Rosalyn Slater; Martijn H Breuning; Anne Hagemeijer; Bert A van der Reijden
Two-colour FISH detection of the inv(16) in interphase nuclei of patients with acute myeloid leukaemia.
British journal of haematology 1999;106(1):111-4.
1999: Bert A van der Reijden; Claudia A J Erpelinck-Verschueren; Bob Löwenberg; Joop H Jansen
TRIADs: a new class of proteins with a novel cysteine-rich signature.
Protein science : a publication of the Protein Society 1999;8(7):1557-61.
1999: Bert A van der Reijden; Hans Dauwerse; Rachel H Giles; Shantie Jagmohan-Changur; cisca wijmenga; P P Liu; B Smit; Hans W Wessels; Geoffrey C Beverstock; M Jotterand Bellomo; Danielle Martinet; Dominique Mühlematter; Marina Lafage-Pochitaloff; Jean Gabert; Josy Reiffers; Chrystèle Bilhou-Nabera; Gert-Jan B van Ommen; Anne Hagemeijer; Martijn H Breuning
Genomic acute myeloid leukemia-associated inv(16)(p13q22) breakpoints are tightly clustered.
Oncogene 1999;18(2):543-50.
1998: E Gomez; Sonja C van der Poel; Joop H Jansen; Bert A van der Reijden; B Lowenberg
Rapid simultaneous screening of factor V Leiden and G20210A prothrombin variant by multiplex polymerase chain reaction on whole blood.
Blood 1998;91(6):2208-9.
1997: Bert A van der Reijden; C D Bloomfield; Ivo P Touw; Joop H Jansen
Acute leukemias with structurally altered core binding factor subunits (t(8;21), inv(16), t(12;21)), 27-28 June 1997, Rotterdam, The Netherlands.
Leukemia 1997;11(12):2217-9.
1997: Rachel H Giles; Johannes G Dauwerse; C Higgins; Fred Petrij; J W Wessels; Geoffrey C Beverstock; H Döhner; M Jotterand Bellomo; J H Frederik Falkenburg; Rosalyn M Slater; Gert-Jan B van Ommen; Anne Hagemeijer; Bert A van der Reijden; Martijn H Breuning
Detection of CBP rearrangements in acute myelogenous leukemia with t(8;16).
Leukemia 1997;11(12):2087-96.
1996: Bert A van der Reijden; Danielle Martinet; J G Dauwerse; Rachel H Giles; J W Wessels; Geoffrey C Beverstock; B Smit; Dominique Mühlematter; M Jotterand Bellomo; Jean Gabert; Marina Lafage-Pochitaloff; J Reiffers; C Bilhou-Nabera; Gert-Jan B van Ommen; Anne Hagemeijer; Martijn H Breuning
Simple method for detection of MYH11 DNA rearrangements in patients with inv(16)(p13q22) and acute myeloid leukemia.
Leukemia 1996;10(9):1459-62.
1996: Bert A van der Reijden; Anne Hagemeijer; Martijn H Breuning
Novel CBFB-MYH11 fusion transcripts or reverse transcription-polymerase chain reaction artifacts?
Blood 1996;87(6):2605.
1996: Bert A van der Reijden; Gert-Jan B van Ommen; Anne Hagemeijer; Martijn H Breuning
Acute myelogenous leukemia: a disorder of gene splicing?
Leukemia 1996;10(2):204-6.
1995: Bert A van der Reijden; M Lombardo; Hans Dauwerse; Rachel H Giles; Dominique Mühlematter; M J Bellomo; Hans W Wessels; Geoffrey C Beverstock; Gert-Jan B van Ommen; Anne Hagemeijer
RT-PCR diagnosis of patients with acute nonlymphocytic leukemia and inv(16)(p13q22) and identification of new alternative splicing in CBFB-MYH11 transcripts.
Blood 1995;86(1):277-82.
1993: Bert A van der Reijden; J G Dauwerse; J W Wessels; Geoffrey C Beverstock; Anne Hagemeijer; Gert-Jan B van Ommen; Martijn H Breuning
A gene for a myosin peptide is disrupted by the inv(16)(p13q22) in acute nonlymphocytic leukemia M4Eo.
Blood 1993;82(10):2948-52.
1993: J G Dauwerse; J W Wessels; Rachel H Giles; Joop Wiegant; Bert A van der Reijden; G Fugazza; E A Jumelet; E Smit; F Baas; Anton K Raap
Cloning the breakpoint cluster region of the inv(16) in acute nonlymphocytic leukemia M4 Eo.
Human molecular genetics 1993;2(10):1527-34.